

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline metabolic process (GO:0006560) | 8.26396385 |
| 2 | transcription from mitochondrial promoter (GO:0006390) | 7.75153060 |
| 3 | embryonic process involved in female pregnancy (GO:0060136) | 7.66958798 |
| 4 | positive regulation of protein homooligomerization (GO:0032464) | 7.47283502 |
| 5 | replication fork processing (GO:0031297) | 6.99055340 |
| 6 | regulation of integrin activation (GO:0033623) | 6.78743196 |
| 7 | oxidative demethylation (GO:0070989) | 6.31593122 |
| 8 | regulation of protein homooligomerization (GO:0032462) | 6.17857959 |
| 9 | establishment of apical/basal cell polarity (GO:0035089) | 6.03346685 |
| 10 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 5.47576097 |
| 11 | cellular response to ATP (GO:0071318) | 5.34563244 |
| 12 | DNA deamination (GO:0045006) | 5.31315059 |
| 13 | positive regulation of developmental pigmentation (GO:0048087) | 5.19592358 |
| 14 | poly(A)+ mRNA export from nucleus (GO:0016973) | 5.12783773 |
| 15 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 5.09194794 |
| 16 | establishment of monopolar cell polarity (GO:0061162) | 5.09194794 |
| 17 | mitochondrial DNA metabolic process (GO:0032042) | 4.95789026 |
| 18 | DNA strand renaturation (GO:0000733) | 4.90263093 |
| 19 | glycosphingolipid catabolic process (GO:0046479) | 4.86723850 |
| 20 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.85499443 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 4.85371224 |
| 22 | embryonic placenta development (GO:0001892) | 4.82400014 |
| 23 | oligosaccharide catabolic process (GO:0009313) | 4.69062931 |
| 24 | negative regulation of JAK-STAT cascade (GO:0046426) | 4.64959357 |
| 25 | amino sugar catabolic process (GO:0046348) | 4.60884155 |
| 26 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.56739192 |
| 27 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.56081910 |
| 28 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.56081910 |
| 29 | negative regulation of protein oligomerization (GO:0032460) | 4.50764901 |
| 30 | mitotic G1 DNA damage checkpoint (GO:0031571) | 4.45248323 |
| 31 | glycolipid catabolic process (GO:0019377) | 4.32069397 |
| 32 | mitotic G1/S transition checkpoint (GO:0044819) | 4.28641921 |
| 33 | positive regulation of protein oligomerization (GO:0032461) | 4.28624390 |
| 34 | viral mRNA export from host cell nucleus (GO:0046784) | 4.26352485 |
| 35 | regulation of mononuclear cell migration (GO:0071675) | 4.24160263 |
| 36 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.22066031 |
| 37 | DNA integration (GO:0015074) | 4.20704896 |
| 38 | G1 DNA damage checkpoint (GO:0044783) | 4.14298588 |
| 39 | ceramide catabolic process (GO:0046514) | 4.09715195 |
| 40 | labyrinthine layer development (GO:0060711) | 4.07271961 |
| 41 | regulation of protein oligomerization (GO:0032459) | 4.06168323 |
| 42 | negative regulation of cell cycle arrest (GO:0071157) | 4.01057498 |
| 43 | positive regulation by host of viral transcription (GO:0043923) | 3.98305623 |
| 44 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.97614405 |
| 45 | mRNA cleavage (GO:0006379) | 3.94974885 |
| 46 | positive regulation of receptor recycling (GO:0001921) | 3.93900854 |
| 47 | cellular response to zinc ion (GO:0071294) | 3.93866726 |
| 48 | negative regulation of Ras GTPase activity (GO:0034261) | 3.92846767 |
| 49 | protein localization to endosome (GO:0036010) | 3.90662784 |
| 50 | response to peptidoglycan (GO:0032494) | 3.85001964 |
| 51 | apoptotic process involved in morphogenesis (GO:0060561) | 3.84488212 |
| 52 | face development (GO:0060324) | 3.72145738 |
| 53 | convergent extension (GO:0060026) | 3.70705558 |
| 54 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.70389744 |
| 55 | membrane tubulation (GO:0097320) | 3.69614932 |
| 56 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.69538561 |
| 57 | glial cell migration (GO:0008347) | 3.68416466 |
| 58 | sulfur amino acid catabolic process (GO:0000098) | 3.67259543 |
| 59 | regulation of translational fidelity (GO:0006450) | 3.62932841 |
| 60 | negative regulation of stress fiber assembly (GO:0051497) | 3.58824489 |
| 61 | positive regulation of heat generation (GO:0031652) | 3.57133761 |
| 62 | protein targeting to vacuole (GO:0006623) | 3.56852943 |
| 63 | protein targeting to lysosome (GO:0006622) | 3.56852943 |
| 64 | establishment of protein localization to vacuole (GO:0072666) | 3.56852943 |
| 65 | regulation of mitochondrial depolarization (GO:0051900) | 3.56297011 |
| 66 | regulation of response to reactive oxygen species (GO:1901031) | 3.56186152 |
| 67 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.56001067 |
| 68 | membrane invagination (GO:0010324) | 3.54468343 |
| 69 | regulation of cholesterol storage (GO:0010885) | 3.53947110 |
| 70 | heme transport (GO:0015886) | 3.53321320 |
| 71 | negative regulation of tumor necrosis factor production (GO:0032720) | 3.52331157 |
| 72 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.52245721 |
| 73 | membrane lipid catabolic process (GO:0046466) | 3.51202410 |
| 74 | regulation of chronic inflammatory response (GO:0002676) | 3.50940736 |
| 75 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.50923152 |
| 76 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.44468901 |
| 77 | negative regulation of cell killing (GO:0031342) | 3.41892789 |
| 78 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.41892789 |
| 79 | sphingolipid catabolic process (GO:0030149) | 3.41582854 |
| 80 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.40961893 |
| 81 | anatomical structure regression (GO:0060033) | 3.40116640 |
| 82 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.39017086 |
| 83 | alkaloid metabolic process (GO:0009820) | 3.38445017 |
| 84 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.35621323 |
| 85 | regulation of RNA export from nucleus (GO:0046831) | 3.33516744 |
| 86 | monocyte chemotaxis (GO:0002548) | 3.32570402 |
| 87 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.30437416 |
| 88 | embryonic camera-type eye development (GO:0031076) | 3.28481479 |
| 89 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.27597287 |
| 90 | base-excision repair (GO:0006284) | 3.26444499 |
| 91 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.22684495 |
| 92 | non-recombinational repair (GO:0000726) | 3.22684495 |
| 93 | N-acetylneuraminate metabolic process (GO:0006054) | 3.22503194 |
| 94 | negative regulation of viral release from host cell (GO:1902187) | 3.21015446 |
| 95 | axon ensheathment in central nervous system (GO:0032291) | 3.20160891 |
| 96 | central nervous system myelination (GO:0022010) | 3.20160891 |
| 97 | regulation of chemokine biosynthetic process (GO:0045073) | 3.19872994 |
| 98 | DNA demethylation (GO:0080111) | 3.18252662 |
| 99 | sphingomyelin metabolic process (GO:0006684) | 3.16785969 |
| 100 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.15950313 |
| 101 | hypotonic response (GO:0006971) | 3.13907868 |
| 102 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.12703495 |
| 103 | mannose metabolic process (GO:0006013) | 3.11747464 |
| 104 | eosinophil chemotaxis (GO:0048245) | 3.11673474 |
| 105 | negative regulation of heart rate (GO:0010459) | 3.11466673 |
| 106 | base-excision repair, AP site formation (GO:0006285) | 3.11363264 |
| 107 | macrophage activation involved in immune response (GO:0002281) | 3.10680439 |
| 108 | establishment of mitochondrion localization (GO:0051654) | 3.09581104 |
| 109 | regulation of podosome assembly (GO:0071801) | 3.09468461 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 3.09053946 |
| 111 | mitotic cell cycle arrest (GO:0071850) | 3.06099886 |
| 112 | regulation of early endosome to late endosome transport (GO:2000641) | 3.05570373 |
| 113 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.05521056 |
| 114 | nuclear envelope reassembly (GO:0031468) | 3.04337163 |
| 115 | mitotic nuclear envelope reassembly (GO:0007084) | 3.04337163 |
| 116 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.04107766 |
| 117 | regulation of glomerular filtration (GO:0003093) | 3.03050954 |
| 118 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.01727064 |
| 119 | neutrophil activation involved in immune response (GO:0002283) | 3.01474272 |
| 120 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.01284602 |
| 121 | lysosome organization (GO:0007040) | 3.00120290 |
| 122 | lytic vacuole organization (GO:0080171) | 3.00120290 |
| 123 | pentose metabolic process (GO:0019321) | 2.98000823 |
| 124 | granulocyte activation (GO:0036230) | 2.96745981 |
| 125 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.96218430 |
| 126 | regulation of cell size (GO:0008361) | 2.95147299 |
| 127 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.93526878 |
| 128 | asymmetric protein localization (GO:0008105) | 2.93108051 |
| 129 | negative regulation of appetite (GO:0032099) | 2.92801286 |
| 130 | negative regulation of response to food (GO:0032096) | 2.92801286 |
| 131 | activation of Rac GTPase activity (GO:0032863) | 2.91870766 |
| 132 | ganglioside metabolic process (GO:0001573) | 2.90015238 |
| 133 | signal complex assembly (GO:0007172) | 2.89795022 |
| 134 | NIK/NF-kappaB signaling (GO:0038061) | 2.89174084 |
| 135 | cellular response to toxic substance (GO:0097237) | 2.89161592 |
| 136 | regulation of fever generation (GO:0031620) | 2.88826860 |
| 137 | trophectodermal cell differentiation (GO:0001829) | 2.88511197 |
| 138 | phagosome maturation (GO:0090382) | 2.87743171 |
| 139 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.86780175 |
| 140 | positive regulation of DNA repair (GO:0045739) | 2.86773258 |
| 141 | regulation of heat generation (GO:0031650) | 2.86449730 |
| 142 | positive regulation of antigen processing and presentation (GO:0002579) | 2.86282781 |
| 143 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.84047751 |
| 144 | negative regulation of mRNA processing (GO:0050686) | 2.83181602 |
| 145 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80782951 |
| 146 | positive regulation of cholesterol efflux (GO:0010875) | 2.77875060 |
| 147 | regulation of T cell tolerance induction (GO:0002664) | 2.76059558 |
| 148 | immunoglobulin mediated immune response (GO:0016064) | 2.72957532 |
| 149 | eosinophil migration (GO:0072677) | 2.72797802 |
| 150 | positive regulation of mast cell activation (GO:0033005) | 2.72248108 |
| 151 | negative regulation of interleukin-1 production (GO:0032692) | 2.67467578 |
| 152 | regulation of vitamin metabolic process (GO:0030656) | 2.64429422 |
| 153 | adhesion of symbiont to host cell (GO:0044650) | 2.63735553 |
| 154 | virion attachment to host cell (GO:0019062) | 2.63735553 |
| 155 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.63114726 |
| 156 | regulation of interleukin-12 production (GO:0032655) | 2.62575986 |
| 157 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.61755457 |
| 158 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.59821771 |
| 159 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.59197818 |
| 160 | positive regulation of leukocyte degranulation (GO:0043302) | 2.58856091 |
| 161 | positive regulation of mast cell degranulation (GO:0043306) | 2.58320924 |
| 162 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.58320924 |
| 163 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.58146445 |
| 164 | regulation of mast cell degranulation (GO:0043304) | 2.56991064 |
| 165 | amyloid precursor protein catabolic process (GO:0042987) | 2.56863738 |
| 166 | keratan sulfate catabolic process (GO:0042340) | 2.54611608 |
| 167 | negative regulation of lipid storage (GO:0010888) | 2.54559190 |
| 168 | regulation of macrophage chemotaxis (GO:0010758) | 2.54171672 |
| 169 | myeloid dendritic cell activation (GO:0001773) | 2.54046490 |
| 170 | T-helper 1 type immune response (GO:0042088) | 2.51311164 |
| 171 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.51074541 |
| 172 | response to muramyl dipeptide (GO:0032495) | 2.50544448 |
| 173 | regulation of monocyte chemotaxis (GO:0090025) | 2.50413619 |
| 174 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.50188754 |
| 175 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.49865035 |
| 176 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.49218631 |
| 177 | regulation of antigen processing and presentation (GO:0002577) | 2.48819705 |
| 178 | regulation of mast cell activation (GO:0033003) | 2.47877323 |
| 179 | regulation of interferon-alpha production (GO:0032647) | 2.47597521 |
| 180 | cellular response to lipopolysaccharide (GO:0071222) | 2.47059192 |
| 181 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.46908794 |
| 182 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.46484559 |
| 183 | detection of molecule of bacterial origin (GO:0032490) | 2.45165651 |
| 184 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.44851058 |
| 185 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.44851058 |
| 186 | response to acidic pH (GO:0010447) | 2.44377193 |
| 187 | type I interferon signaling pathway (GO:0060337) | 2.44340045 |
| 188 | cellular response to type I interferon (GO:0071357) | 2.44340045 |
| 189 | cellular response to molecule of bacterial origin (GO:0071219) | 2.43520622 |
| 190 | germinal center formation (GO:0002467) | 2.43466984 |
| 191 | vitamin D metabolic process (GO:0042359) | 2.42860216 |
| 192 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.42800618 |
| 193 | response to type I interferon (GO:0034340) | 2.41820269 |
| 194 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.41121092 |
| 195 | pH reduction (GO:0045851) | 2.39538255 |
| 196 | adhesion of symbiont to host (GO:0044406) | 2.39460965 |
| 197 | proline biosynthetic process (GO:0006561) | 10.5903447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.33911432 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.31726522 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.58083574 |
| 4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.58083574 |
| 5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.58083574 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.55750524 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.36616972 |
| 8 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 3.35664395 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.18132067 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.05553873 |
| 11 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.99932551 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.92549609 |
| 13 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.86149008 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76054100 |
| 15 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.74384138 |
| 16 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.63002284 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.39239569 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38401344 |
| 19 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.35341424 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34531631 |
| 21 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.32679705 |
| 22 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 2.29374876 |
| 23 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.25010718 |
| 24 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.22632428 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.19819826 |
| 26 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.10903976 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.10479926 |
| 28 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 2.09243863 |
| 29 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.09129653 |
| 30 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07379521 |
| 31 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03147630 |
| 32 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 2.02597298 |
| 33 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.89593803 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87903243 |
| 35 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.87383373 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85420251 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81881874 |
| 38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.76268080 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74216533 |
| 40 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.71317514 |
| 41 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.69362528 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67821203 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67758705 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67481371 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66211447 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.64535419 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63713093 |
| 48 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.59806174 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56386515 |
| 50 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56250476 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56177558 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56053101 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54780303 |
| 54 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.54626561 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.53093875 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52031616 |
| 57 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51543296 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49947065 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49530081 |
| 60 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.46666125 |
| 61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.46310975 |
| 62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46169102 |
| 63 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.45847664 |
| 64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42936656 |
| 65 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.39243340 |
| 66 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37712275 |
| 67 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.37347995 |
| 68 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.37170758 |
| 69 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.36157514 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.35544739 |
| 71 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.35522396 |
| 72 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.35428921 |
| 73 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34662663 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34041571 |
| 75 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.33718826 |
| 76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33406831 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32971939 |
| 78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32662577 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30776127 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29111261 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27576908 |
| 82 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.26989666 |
| 83 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.26600819 |
| 84 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.26384986 |
| 85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25749534 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25653747 |
| 87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25134406 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25119965 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24917810 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24649266 |
| 91 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.23802748 |
| 92 | MYC_22102868_ChIP-Seq_BL_Human | 1.23471272 |
| 93 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22489126 |
| 94 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22220622 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21882219 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21820493 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.21356593 |
| 98 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.20581293 |
| 99 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.20328919 |
| 100 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19424253 |
| 101 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19398649 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18808941 |
| 103 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17838117 |
| 104 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15517761 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15073261 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14370052 |
| 107 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.14326438 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14224283 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13883736 |
| 110 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.13363310 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11717648 |
| 112 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.11651107 |
| 113 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.11420262 |
| 114 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10389001 |
| 115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09934880 |
| 116 | * P68_20966046_ChIP-Seq_HELA_Human | 1.09233550 |
| 117 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09232959 |
| 118 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09168853 |
| 119 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08939412 |
| 120 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07435703 |
| 121 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 1.06686452 |
| 122 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06648365 |
| 123 | MAF_26560356_Chip-Seq_TH1_Human | 1.05436830 |
| 124 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.04657236 |
| 125 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.04135801 |
| 126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03205575 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02595200 |
| 128 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.02188951 |
| 129 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.02180049 |
| 130 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02126391 |
| 131 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00964037 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00204338 |
| 133 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.99874424 |
| 134 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99252970 |
| 135 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98726506 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98519393 |
| 137 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.98364987 |
| 138 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98160058 |
| 139 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.97479377 |
| 140 | MAF_26560356_Chip-Seq_TH2_Human | 0.97464022 |
| 141 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.97263662 |
| 142 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97121134 |
| 143 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97020622 |
| 144 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96973233 |
| 145 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96459163 |
| 146 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96096095 |
| 147 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96045673 |
| 148 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95851692 |
| 149 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95548522 |
| 150 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94762663 |
| 151 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94644817 |
| 152 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.94491540 |
| 153 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94101020 |
| 154 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93882150 |
| 155 | SA1_27219007_Chip-Seq_Bcells_Human | 0.93794825 |
| 156 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93712875 |
| 157 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93235627 |
| 158 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93209930 |
| 159 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92272545 |
| 160 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.92191645 |
| 161 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91907049 |
| 162 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.90850661 |
| 163 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89551512 |
| 164 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86335419 |
| 165 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.84821744 |
| 166 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84138054 |
| 167 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.83438808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 5.66983899 |
| 2 | MP0005171_absent_coat_pigmentation | 5.10412344 |
| 3 | MP0009278_abnormal_bone_marrow | 4.95955607 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.97373337 |
| 5 | MP0003303_peritoneal_inflammation | 3.85842662 |
| 6 | MP0010030_abnormal_orbit_morphology | 3.19314703 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.18736004 |
| 8 | MP0002009_preneoplasia | 3.09297497 |
| 9 | MP0005671_abnormal_response_to | 3.08316956 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.95592113 |
| 11 | MP0003436_decreased_susceptibility_to | 2.94835032 |
| 12 | MP0003724_increased_susceptibility_to | 2.83374605 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.83158691 |
| 14 | MP0000604_amyloidosis | 2.79308965 |
| 15 | MP0004233_abnormal_muscle_weight | 2.65727339 |
| 16 | MP0009785_altered_susceptibility_to | 2.50055558 |
| 17 | MP0002419_abnormal_innate_immunity | 2.49753016 |
| 18 | MP0002254_reproductive_system_inflammat | 2.40461005 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.29120517 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.28128934 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.28076244 |
| 22 | MP0004510_myositis | 2.27457550 |
| 23 | MP0005387_immune_system_phenotype | 2.25634356 |
| 24 | MP0001790_abnormal_immune_system | 2.25634356 |
| 25 | MP0003453_abnormal_keratinocyte_physiol | 2.16442441 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 2.14069328 |
| 27 | MP0005025_abnormal_response_to | 2.12888533 |
| 28 | MP0004133_heterotaxia | 2.11351016 |
| 29 | MP0003283_abnormal_digestive_organ | 2.10320744 |
| 30 | MP0001545_abnormal_hematopoietic_system | 2.10104889 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 2.10104889 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 2.06388258 |
| 33 | MP0000015_abnormal_ear_pigmentation | 2.05832765 |
| 34 | MP0008995_early_reproductive_senescence | 2.05561371 |
| 35 | MP0000343_altered_response_to | 2.01787184 |
| 36 | MP0009764_decreased_sensitivity_to | 1.95241176 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.90641546 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.88107933 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.88085885 |
| 40 | MP0002723_abnormal_immune_serum | 1.86944932 |
| 41 | MP0006082_CNS_inflammation | 1.84266156 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.82810507 |
| 43 | MP0003329_amyloid_beta_deposits | 1.79483509 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.77711856 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.77448608 |
| 46 | MP0002249_abnormal_larynx_morphology | 1.76757071 |
| 47 | MP0002282_abnormal_trachea_morphology | 1.76717831 |
| 48 | MP0005310_abnormal_salivary_gland | 1.76396564 |
| 49 | MP0000579_abnormal_nail_morphology | 1.66576949 |
| 50 | MP0001800_abnormal_humoral_immune | 1.62688569 |
| 51 | MP0005451_abnormal_body_composition | 1.60571895 |
| 52 | MP0000462_abnormal_digestive_system | 1.60186121 |
| 53 | MP0000371_diluted_coat_color | 1.58343701 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.56577360 |
| 55 | MP0001819_abnormal_immune_cell | 1.55776400 |
| 56 | MP0009840_abnormal_foam_cell | 1.55718426 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.53224641 |
| 58 | MP0000685_abnormal_immune_system | 1.52159880 |
| 59 | MP0004947_skin_inflammation | 1.51877265 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.48898642 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 1.47382157 |
| 62 | MP0008469_abnormal_protein_level | 1.47240747 |
| 63 | MP0000639_abnormal_adrenal_gland | 1.45146860 |
| 64 | MP0001293_anophthalmia | 1.39356832 |
| 65 | MP0001853_heart_inflammation | 1.38573395 |
| 66 | MP0000470_abnormal_stomach_morphology | 1.37068418 |
| 67 | MP0001340_abnormal_eyelid_morphology | 1.36074382 |
| 68 | MP0000920_abnormal_myelination | 1.34818855 |
| 69 | MP0003195_calcinosis | 1.32212626 |
| 70 | MP0005365_abnormal_bile_salt | 1.30753167 |
| 71 | MP0003448_altered_tumor_morphology | 1.28341634 |
| 72 | MP0006054_spinal_hemorrhage | 1.26023593 |
| 73 | MP0010155_abnormal_intestine_physiology | 1.25192964 |
| 74 | MP0002086_abnormal_extraembryonic_tissu | 1.20289481 |
| 75 | MP0002405_respiratory_system_inflammati | 1.19154702 |
| 76 | MP0003786_premature_aging | 1.17197465 |
| 77 | MP0003634_abnormal_glial_cell | 1.17190692 |
| 78 | MP0003119_abnormal_digestive_system | 1.16117554 |
| 79 | MP0002060_abnormal_skin_morphology | 1.15615057 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 1.14842156 |
| 81 | MP0004142_abnormal_muscle_tone | 1.11428386 |
| 82 | MP0002269_muscular_atrophy | 1.08932402 |
| 83 | MP0005166_decreased_susceptibility_to | 1.07159606 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.06300212 |
| 85 | MP0002084_abnormal_developmental_patter | 1.06251568 |
| 86 | MP0003690_abnormal_glial_cell | 1.05741069 |
| 87 | MP0001324_abnormal_eye_pigmentation | 1.03987462 |
| 88 | MP0002090_abnormal_vision | 1.03295543 |
| 89 | MP0003828_pulmonary_edema | 1.02783590 |
| 90 | MP0000716_abnormal_immune_system | 0.99956262 |
| 91 | MP0004197_abnormal_fetal_growth/weight/ | 0.99653271 |
| 92 | MP0003879_abnormal_hair_cell | 0.99634596 |
| 93 | MP0000858_altered_metastatic_potential | 0.98993407 |
| 94 | MP0005257_abnormal_intraocular_pressure | 0.96877388 |
| 95 | MP0002796_impaired_skin_barrier | 0.96262946 |
| 96 | MP0003567_abnormal_fetal_cardiomyocyte | 0.95430657 |
| 97 | MP0002075_abnormal_coat/hair_pigmentati | 0.94933788 |
| 98 | MP0001697_abnormal_embryo_size | 0.94448014 |
| 99 | MP0002111_abnormal_tail_morphology | 0.94389289 |
| 100 | MP0003045_fibrosis | 0.94245140 |
| 101 | MP0000467_abnormal_esophagus_morphology | 0.93589422 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.93169880 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.93074977 |
| 104 | MP0002933_joint_inflammation | 0.92955941 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.91356430 |
| 106 | MP0002932_abnormal_joint_morphology | 0.90452019 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.90265003 |
| 108 | MP0003806_abnormal_nucleotide_metabolis | 0.89714229 |
| 109 | MP0008004_abnormal_stomach_pH | 0.89379572 |
| 110 | MP0002085_abnormal_embryonic_tissue | 0.89345379 |
| 111 | MP0005464_abnormal_platelet_physiology | 0.86572282 |
| 112 | MP0005390_skeleton_phenotype | 0.86401725 |
| 113 | MP0002653_abnormal_ependyma_morphology | 0.85559749 |
| 114 | MP0000689_abnormal_spleen_morphology | 0.85504340 |
| 115 | MP0000762_abnormal_tongue_morphology | 0.85239697 |
| 116 | MP0003136_yellow_coat_color | 0.84330248 |
| 117 | MP0000490_abnormal_crypts_of | 0.82416630 |
| 118 | MP0002837_dystrophic_cardiac_calcinosis | 0.82291973 |
| 119 | MP0001501_abnormal_sleep_pattern | 0.81311790 |
| 120 | MP0004134_abnormal_chest_morphology | 0.80679430 |
| 121 | MP0010094_abnormal_chromosome_stability | 0.80568692 |
| 122 | MP0009333_abnormal_splenocyte_physiolog | 0.79512942 |
| 123 | MP0005508_abnormal_skeleton_morphology | 0.76801453 |
| 124 | MP0005647_abnormal_sex_gland | 0.76499767 |
| 125 | MP0002166_altered_tumor_susceptibility | 0.75341075 |
| 126 | MP0005023_abnormal_wound_healing | 0.74979506 |
| 127 | MP0003075_altered_response_to | 0.74916308 |
| 128 | MP0005266_abnormal_metabolism | 0.74863711 |
| 129 | MP0008932_abnormal_embryonic_tissue | 0.74551963 |
| 130 | MP0004185_abnormal_adipocyte_glucose | 0.72848602 |
| 131 | MP0003795_abnormal_bone_structure | 0.72624607 |
| 132 | MP0009115_abnormal_fat_cell | 0.72496018 |
| 133 | MP0001186_pigmentation_phenotype | 0.72408166 |
| 134 | MP0003633_abnormal_nervous_system | 0.71960858 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.71718174 |
| 136 | MP0005377_hearing/vestibular/ear_phenot | 0.71168888 |
| 137 | MP0003878_abnormal_ear_physiology | 0.71168888 |
| 138 | MP0003279_aneurysm | 0.70817167 |
| 139 | MP0004019_abnormal_vitamin_homeostasis | 0.69990205 |
| 140 | MP0008874_decreased_physiological_sensi | 0.69747892 |
| 141 | MP0001542_abnormal_bone_strength | 0.69422184 |
| 142 | MP0001663_abnormal_digestive_system | 0.68143727 |
| 143 | MP0002114_abnormal_axial_skeleton | 0.67155258 |
| 144 | MP0008877_abnormal_DNA_methylation | 0.65803290 |
| 145 | MP0004858_abnormal_nervous_system | 0.65778341 |
| 146 | MP0005164_abnormal_response_to | 0.65214621 |
| 147 | MP0002429_abnormal_blood_cell | 0.64910331 |
| 148 | MP0002229_neurodegeneration | 0.64365567 |
| 149 | MP0003632_abnormal_nervous_system | 0.63431222 |
| 150 | MP0009763_increased_sensitivity_to | 0.62990340 |
| 151 | MP0001672_abnormal_embryogenesis/_devel | 0.62546732 |
| 152 | MP0005380_embryogenesis_phenotype | 0.62546732 |
| 153 | MP0003631_nervous_system_phenotype | 0.62368205 |
| 154 | MP0001873_stomach_inflammation | 0.61635516 |
| 155 | MP0003755_abnormal_palate_morphology | 0.61387656 |
| 156 | MP0000432_abnormal_head_morphology | 0.61369346 |
| 157 | MP0005595_abnormal_vascular_smooth | 0.60516641 |
| 158 | MP0002064_seizures | 0.60429715 |
| 159 | MP0003935_abnormal_craniofacial_develop | 0.60365820 |
| 160 | MP0002277_abnormal_respiratory_mucosa | 0.60043295 |
| 161 | MP0002108_abnormal_muscle_morphology | 0.59947800 |
| 162 | MP0002693_abnormal_pancreas_physiology | 0.58420618 |
| 163 | MP0002398_abnormal_bone_marrow | 0.58028839 |
| 164 | MP0002019_abnormal_tumor_incidence | 0.57787451 |
| 165 | MP0008260_abnormal_autophagy | 0.57402377 |
| 166 | MP0004742_abnormal_vestibular_system | 0.57292082 |
| 167 | MP0009765_abnormal_xenobiotic_induced | 0.57246868 |
| 168 | MP0010386_abnormal_urinary_bladder | 0.56493399 |
| 169 | MP0000367_abnormal_coat/_hair | 0.56348469 |
| 170 | MP0010630_abnormal_cardiac_muscle | 0.56240441 |
| 171 | MP0003137_abnormal_impulse_conducting | 0.56209811 |
| 172 | MP0003638_abnormal_response/metabolism_ | 0.56068577 |
| 173 | MP0005253_abnormal_eye_physiology | 0.53762652 |
| 174 | MP0001784_abnormal_fluid_regulation | 0.53624819 |
| 175 | MP0005391_vision/eye_phenotype | 0.53464161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 9.02641322 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 9.02641322 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 9.02641322 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 6.47613882 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 6.17331309 |
| 6 | Pustule (HP:0200039) | 5.62654880 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.19206773 |
| 8 | Concave nail (HP:0001598) | 5.17154286 |
| 9 | Rib fusion (HP:0000902) | 5.15549892 |
| 10 | Turricephaly (HP:0000262) | 5.15545838 |
| 11 | Rectal fistula (HP:0100590) | 5.10121541 |
| 12 | Rectovaginal fistula (HP:0000143) | 5.10121541 |
| 13 | Intestinal fistula (HP:0100819) | 4.82234174 |
| 14 | Ulnar bowing (HP:0003031) | 4.79235921 |
| 15 | Loss of speech (HP:0002371) | 4.73414743 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.70219663 |
| 17 | Vaginal fistula (HP:0004320) | 4.64982114 |
| 18 | Alopecia of scalp (HP:0002293) | 4.63465654 |
| 19 | Anteriorly placed anus (HP:0001545) | 4.56410788 |
| 20 | Facial hemangioma (HP:0000329) | 4.40479942 |
| 21 | Increased IgM level (HP:0003496) | 4.39827515 |
| 22 | Coronal craniosynostosis (HP:0004440) | 4.35781479 |
| 23 | Dysostosis multiplex (HP:0000943) | 4.30316796 |
| 24 | Disinhibition (HP:0000734) | 4.30183539 |
| 25 | Annular pancreas (HP:0001734) | 4.22495352 |
| 26 | Mutism (HP:0002300) | 4.22020319 |
| 27 | Premature skin wrinkling (HP:0100678) | 4.16210022 |
| 28 | Hypochromic microcytic anemia (HP:0004840) | 4.06091141 |
| 29 | Poikiloderma (HP:0001029) | 4.01278960 |
| 30 | Alacrima (HP:0000522) | 3.97104155 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.89858975 |
| 32 | Mucopolysacchariduria (HP:0008155) | 3.89858975 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.84867263 |
| 34 | Clumsiness (HP:0002312) | 3.71465115 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.62041361 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.62041361 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.62041361 |
| 38 | Nuclear cataract (HP:0100018) | 3.57407905 |
| 39 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.46319995 |
| 40 | Orchitis (HP:0100796) | 3.44733582 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 3.44613764 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 3.43553680 |
| 43 | Optic neuritis (HP:0100653) | 3.43553680 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.42927731 |
| 45 | Male infertility (HP:0003251) | 3.39896425 |
| 46 | Abnormal hemoglobin (HP:0011902) | 3.38810425 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 3.35695290 |
| 48 | Eczematoid dermatitis (HP:0000976) | 3.31548860 |
| 49 | Myositis (HP:0100614) | 3.28442328 |
| 50 | Short humerus (HP:0005792) | 3.24719117 |
| 51 | Broad alveolar ridges (HP:0000187) | 3.23561456 |
| 52 | Albinism (HP:0001022) | 3.21136348 |
| 53 | Recurrent abscess formation (HP:0002722) | 3.17532953 |
| 54 | Stomatitis (HP:0010280) | 3.17161990 |
| 55 | Vertebral hypoplasia (HP:0008417) | 3.11565948 |
| 56 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.11565948 |
| 57 | Tongue fasciculations (HP:0001308) | 3.11421268 |
| 58 | Abnormality of male internal genitalia (HP:0000022) | 3.08964538 |
| 59 | Diaphragmatic weakness (HP:0009113) | 3.06370997 |
| 60 | Apathy (HP:0000741) | 3.03244542 |
| 61 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.01814811 |
| 62 | Diminished motivation (HP:0000745) | 3.01437672 |
| 63 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.98910580 |
| 64 | Large for gestational age (HP:0001520) | 2.98375653 |
| 65 | Intestinal atresia (HP:0011100) | 2.94078217 |
| 66 | Decreased lacrimation (HP:0000633) | 2.93408980 |
| 67 | Orthostatic hypotension (HP:0001278) | 2.92594416 |
| 68 | Dysautonomia (HP:0002459) | 2.91935193 |
| 69 | Neuronal loss in central nervous system (HP:0002529) | 2.85371890 |
| 70 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.84582972 |
| 71 | Aplasia of the musculature (HP:0100854) | 2.81888407 |
| 72 | Hypokinesia (HP:0002375) | 2.81368010 |
| 73 | Muscle fibrillation (HP:0010546) | 2.81130422 |
| 74 | Retinal atrophy (HP:0001105) | 2.79759919 |
| 75 | J-shaped sella turcica (HP:0002680) | 2.74713398 |
| 76 | Joint stiffness (HP:0001387) | 2.73414933 |
| 77 | Mediastinal lymphadenopathy (HP:0100721) | 2.73343272 |
| 78 | Cerebral inclusion bodies (HP:0100314) | 2.72788741 |
| 79 | Short chin (HP:0000331) | 2.69636390 |
| 80 | Cerebral aneurysm (HP:0004944) | 2.67765928 |
| 81 | Congenital hip dislocation (HP:0001374) | 2.67710447 |
| 82 | Choanal stenosis (HP:0000452) | 2.66329252 |
| 83 | Absent radius (HP:0003974) | 2.61508165 |
| 84 | Prolonged neonatal jaundice (HP:0006579) | 2.60240852 |
| 85 | Hematochezia (HP:0002573) | 2.59703510 |
| 86 | Inappropriate behavior (HP:0000719) | 2.57382214 |
| 87 | Bowed forearm bones (HP:0003956) | 2.56001391 |
| 88 | Bowing of the arm (HP:0006488) | 2.56001391 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54979386 |
| 90 | Hypotrichosis (HP:0001006) | 2.52955619 |
| 91 | Supranuclear gaze palsy (HP:0000605) | 2.49209694 |
| 92 | Bifid uvula (HP:0000193) | 2.48573460 |
| 93 | Hamartoma (HP:0010566) | 2.46737443 |
| 94 | Absent forearm bone (HP:0003953) | 2.46422436 |
| 95 | Aplasia involving forearm bones (HP:0009822) | 2.46422436 |
| 96 | T lymphocytopenia (HP:0005403) | 2.43598731 |
| 97 | Polycythemia (HP:0001901) | 2.43122610 |
| 98 | Squamous cell carcinoma (HP:0002860) | 2.43108187 |
| 99 | Metaphyseal irregularity (HP:0003025) | 2.39887407 |
| 100 | Increased serum ferritin (HP:0003281) | 2.38875749 |
| 101 | Purpura (HP:0000979) | 2.34447135 |
| 102 | Dementia (HP:0000726) | 2.33960947 |
| 103 | Hypotelorism (HP:0000601) | 2.32754037 |
| 104 | Abnormality of the aortic arch (HP:0012303) | 2.32051812 |
| 105 | Pulmonary infiltrates (HP:0002113) | 2.30990927 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 2.30354832 |
| 107 | Global brain atrophy (HP:0002283) | 2.28378861 |
| 108 | Narrow nasal bridge (HP:0000446) | 2.27393789 |
| 109 | Diminished movement (HP:0002374) | 2.27232355 |
| 110 | Agnosia (HP:0010524) | 2.23321716 |
| 111 | Xanthomatosis (HP:0000991) | 2.22987009 |
| 112 | Upper motor neuron abnormality (HP:0002127) | 2.22809470 |
| 113 | Peripheral demyelination (HP:0011096) | 2.21636842 |
| 114 | Glomerulonephritis (HP:0000099) | 2.21347505 |
| 115 | Split hand (HP:0001171) | 2.21194958 |
| 116 | Thickened helices (HP:0000391) | 2.20630139 |
| 117 | Colitis (HP:0002583) | 2.17561714 |
| 118 | Progressive neurologic deterioration (HP:0002344) | 2.16870198 |
| 119 | IgA deficiency (HP:0002720) | 2.16790928 |
| 120 | Obstructive lung disease (HP:0006536) | 2.12930047 |
| 121 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12930047 |
| 122 | Hypochromic anemia (HP:0001931) | 2.12773837 |
| 123 | Growth hormone excess (HP:0000845) | 2.09302408 |
| 124 | Abnormality of T cell number (HP:0011839) | 2.09011331 |
| 125 | Vertebral fusion (HP:0002948) | 2.08548076 |
| 126 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08332282 |
| 127 | Basal cell carcinoma (HP:0002671) | 2.08110603 |
| 128 | Myocardial infarction (HP:0001658) | 2.07894500 |
| 129 | Cardiomegaly (HP:0001640) | 2.07332247 |
| 130 | Mesangial abnormality (HP:0001966) | 2.05773093 |
| 131 | Hepatosplenomegaly (HP:0001433) | 2.05477579 |
| 132 | Keratoconjunctivitis sicca (HP:0001097) | 2.05150670 |
| 133 | Agitation (HP:0000713) | 2.03442814 |
| 134 | Increased CSF protein (HP:0002922) | 2.00348493 |
| 135 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.99876439 |
| 136 | Abnormality of placental membranes (HP:0011409) | 1.98800547 |
| 137 | Amniotic constriction ring (HP:0009775) | 1.98800547 |
| 138 | Keratoconjunctivitis (HP:0001096) | 1.97961527 |
| 139 | Capillary hemangiomas (HP:0005306) | 1.96870073 |
| 140 | Hemoptysis (HP:0002105) | 1.96526163 |
| 141 | Cheilitis (HP:0100825) | 1.96261018 |
| 142 | Pathologic fracture (HP:0002756) | 1.95944602 |
| 143 | Recurrent skin infections (HP:0001581) | 1.95410745 |
| 144 | Amelogenesis imperfecta (HP:0000705) | 1.95288113 |
| 145 | Protuberant abdomen (HP:0001538) | 1.93904344 |
| 146 | Premature graying of hair (HP:0002216) | 1.92702010 |
| 147 | Bulbar palsy (HP:0001283) | 1.92206815 |
| 148 | Neurofibrillary tangles (HP:0002185) | 1.91891553 |
| 149 | Personality changes (HP:0000751) | 1.91447995 |
| 150 | Polyneuropathy (HP:0001271) | 1.90500036 |
| 151 | Hypoplasia of the ulna (HP:0003022) | 1.89517581 |
| 152 | Gastrointestinal atresia (HP:0002589) | 1.89455207 |
| 153 | Thoracic kyphosis (HP:0002942) | 1.89253626 |
| 154 | Axonal loss (HP:0003447) | 1.83969893 |
| 155 | Amyloidosis (HP:0011034) | 1.82558618 |
| 156 | Abnormality of the periventricular white matter (HP:0002518) | 1.80585880 |
| 157 | Generalized amyotrophy (HP:0003700) | 1.80461752 |
| 158 | Abnormality of iron homeostasis (HP:0011031) | 1.79992072 |
| 159 | Memory impairment (HP:0002354) | 1.77434157 |
| 160 | Depressed nasal tip (HP:0000437) | 1.76901349 |
| 161 | Lower limb hyperreflexia (HP:0002395) | 1.76872665 |
| 162 | Basal ganglia calcification (HP:0002135) | 1.76569420 |
| 163 | Increased number of teeth (HP:0011069) | 1.76400673 |
| 164 | Ectopic anus (HP:0004397) | 1.75505767 |
| 165 | Volvulus (HP:0002580) | 1.75304431 |
| 166 | Absent thumb (HP:0009777) | 1.74882399 |
| 167 | Acne (HP:0001061) | 1.73439637 |
| 168 | Recurrent fungal infections (HP:0002841) | 1.71010799 |
| 169 | Ovoid vertebral bodies (HP:0003300) | 1.69763278 |
| 170 | Zonular cataract (HP:0010920) | 1.68756074 |
| 171 | Coarse hair (HP:0002208) | 1.68172976 |
| 172 | Interstitial pulmonary disease (HP:0006530) | 1.68148481 |
| 173 | Redundant skin (HP:0001582) | 1.67536792 |
| 174 | Polyphagia (HP:0002591) | 1.62188885 |
| 175 | Deformed sella turcica (HP:0002681) | 1.62019177 |
| 176 | Urinary incontinence (HP:0000020) | 1.61968875 |
| 177 | Bone pain (HP:0002653) | 1.60749683 |
| 178 | Thin bony cortex (HP:0002753) | 1.60129744 |
| 179 | Macroglossia (HP:0000158) | 1.59946294 |
| 180 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.58890682 |
| 181 | Parakeratosis (HP:0001036) | 1.58710996 |
| 182 | Pulmonary embolism (HP:0002204) | 1.58700286 |
| 183 | Poor head control (HP:0002421) | 1.57932618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 6.18341167 |
| 2 | MAPK15 | 5.15004436 |
| 3 | DDR2 | 4.94146797 |
| 4 | MAP3K6 | 4.23803437 |
| 5 | IRAK3 | 3.98020106 |
| 6 | FGR | 3.52231734 |
| 7 | GRK7 | 3.39718691 |
| 8 | MAP3K11 | 3.15473334 |
| 9 | TYRO3 | 3.05501739 |
| 10 | PINK1 | 2.98625701 |
| 11 | MATK | 2.82078121 |
| 12 | TXK | 2.75194885 |
| 13 | CSK | 2.48298368 |
| 14 | PRKD2 | 2.46862229 |
| 15 | UHMK1 | 2.45254352 |
| 16 | ADRBK2 | 2.39409573 |
| 17 | TBK1 | 2.22972492 |
| 18 | TRPM7 | 2.21015142 |
| 19 | MAP3K14 | 2.14942434 |
| 20 | BMX | 2.13053832 |
| 21 | YES1 | 2.11128277 |
| 22 | ACVR1B | 2.01923251 |
| 23 | PIM2 | 2.00862506 |
| 24 | DYRK1B | 1.92150522 |
| 25 | DAPK1 | 1.92014546 |
| 26 | NME2 | 1.90028835 |
| 27 | TYK2 | 1.86551808 |
| 28 | TGFBR2 | 1.84367042 |
| 29 | PDGFRA | 1.63139999 |
| 30 | IRAK4 | 1.62756547 |
| 31 | ERN1 | 1.52944846 |
| 32 | RIPK4 | 1.52591209 |
| 33 | TAOK1 | 1.51215330 |
| 34 | MAP3K3 | 1.48443372 |
| 35 | RIPK1 | 1.48254451 |
| 36 | CAMKK2 | 1.45378960 |
| 37 | CAMK1D | 1.43744287 |
| 38 | IKBKE | 1.40977793 |
| 39 | MAP2K6 | 1.39840443 |
| 40 | ZAP70 | 1.39787250 |
| 41 | CDK6 | 1.36604035 |
| 42 | CDK7 | 1.34371961 |
| 43 | SIK3 | 1.34138940 |
| 44 | DAPK2 | 1.29396721 |
| 45 | PIM1 | 1.28408542 |
| 46 | MAP2K3 | 1.27812785 |
| 47 | EPHB1 | 1.26603975 |
| 48 | GSK3A | 1.24139280 |
| 49 | PHKG1 | 1.18860135 |
| 50 | PHKG2 | 1.18860135 |
| 51 | RPS6KL1 | 1.11878985 |
| 52 | RPS6KC1 | 1.11878985 |
| 53 | CHUK | 1.11764231 |
| 54 | AKT3 | 1.08660406 |
| 55 | RPS6KA6 | 1.02317114 |
| 56 | MOS | 1.01091075 |
| 57 | ABL2 | 0.99267098 |
| 58 | JAK3 | 0.98143100 |
| 59 | FES | 0.97826241 |
| 60 | PRPF4B | 0.96747160 |
| 61 | MAPK11 | 0.96144616 |
| 62 | CDC42BPA | 0.95828008 |
| 63 | RPS6KA2 | 0.94086149 |
| 64 | CAMKK1 | 0.92835086 |
| 65 | STK39 | 0.88307431 |
| 66 | PRKD3 | 0.88038773 |
| 67 | MAP3K13 | 0.84784114 |
| 68 | BLK | 0.84460531 |
| 69 | MAP4K1 | 0.84444252 |
| 70 | MARK3 | 0.82551562 |
| 71 | JAK1 | 0.81488732 |
| 72 | MAP3K1 | 0.80676556 |
| 73 | ITK | 0.80342364 |
| 74 | LIMK1 | 0.78116618 |
| 75 | HIPK2 | 0.77883374 |
| 76 | MAP3K10 | 0.75710810 |
| 77 | TAOK3 | 0.75369255 |
| 78 | IRAK1 | 0.73696160 |
| 79 | IRAK2 | 0.72828787 |
| 80 | TRIB3 | 0.70965928 |
| 81 | SYK | 0.70769660 |
| 82 | CSNK1G1 | 0.70696132 |
| 83 | MTOR | 0.68899084 |
| 84 | TESK1 | 0.68617420 |
| 85 | HCK | 0.67569735 |
| 86 | CHEK2 | 0.66408054 |
| 87 | LATS2 | 0.66236909 |
| 88 | EPHA3 | 0.65746657 |
| 89 | LYN | 0.65135942 |
| 90 | CAMK2B | 0.62711083 |
| 91 | PDGFRB | 0.62252974 |
| 92 | CAMK1G | 0.61182136 |
| 93 | MAPK12 | 0.60153095 |
| 94 | PAK6 | 0.59794924 |
| 95 | EGFR | 0.59521514 |
| 96 | TESK2 | 0.57573465 |
| 97 | PDK1 | 0.55343877 |
| 98 | PDPK1 | 0.55020040 |
| 99 | LCK | 0.54617423 |
| 100 | PRKAA1 | 0.52209074 |
| 101 | NTRK2 | 0.52060839 |
| 102 | PDK2 | 0.51849396 |
| 103 | CAMK2G | 0.50951190 |
| 104 | FGFR4 | 0.50904107 |
| 105 | PRKAA2 | 0.50648220 |
| 106 | KIT | 0.50595234 |
| 107 | RAF1 | 0.50284980 |
| 108 | IKBKB | 0.48615562 |
| 109 | MAP3K5 | 0.47920998 |
| 110 | PRKD1 | 0.47854198 |
| 111 | RPS6KA1 | 0.47303713 |
| 112 | KDR | 0.45813914 |
| 113 | OXSR1 | 0.44059280 |
| 114 | BTK | 0.43619694 |
| 115 | CAMK2D | 0.43551878 |
| 116 | MARK2 | 0.41538448 |
| 117 | INSR | 0.41265567 |
| 118 | MAPK1 | 0.41020315 |
| 119 | MAPK3 | 0.40439787 |
| 120 | MET | 0.40359428 |
| 121 | TNK2 | 0.40248423 |
| 122 | PTK2 | 0.39181733 |
| 123 | MAPK10 | 0.36744800 |
| 124 | PRKCQ | 0.36075616 |
| 125 | PRKCH | 0.36011699 |
| 126 | MAPK4 | 0.36007191 |
| 127 | PAK2 | 0.35495343 |
| 128 | DYRK3 | 0.35298997 |
| 129 | MAP3K9 | 0.34379785 |
| 130 | MAPK7 | 0.33361308 |
| 131 | STK10 | 0.32960034 |
| 132 | FYN | 0.31482386 |
| 133 | TAOK2 | 0.31237414 |
| 134 | BMPR2 | 0.30433013 |
| 135 | CDK12 | 0.29273445 |
| 136 | ABL1 | 0.28959311 |
| 137 | MUSK | 0.28287690 |
| 138 | CSNK1G2 | 0.28148719 |
| 139 | CSNK1A1L | 0.27373543 |
| 140 | CAMK2A | 0.27221834 |
| 141 | PKN1 | 0.27144700 |
| 142 | CSNK2A1 | 0.26492624 |
| 143 | CSF1R | 0.26289587 |
| 144 | CDK2 | 0.25731086 |
| 145 | DYRK2 | 0.24703821 |
| 146 | CSNK1G3 | 0.24690112 |
| 147 | SGK1 | 0.24482582 |
| 148 | SIK1 | 0.24314337 |
| 149 | MELK | 0.23895737 |
| 150 | PLK1 | 0.23877488 |
| 151 | MAPKAPK2 | 0.23280694 |
| 152 | PRKCD | 0.21263372 |
| 153 | STK3 | 0.20403614 |
| 154 | MAPK14 | 0.19984644 |
| 155 | CLK1 | 0.18236727 |
| 156 | JAK2 | 0.17861624 |
| 157 | PRKCZ | 0.17315915 |
| 158 | CSNK2A2 | 0.15668560 |
| 159 | SIK2 | 0.15112237 |
| 160 | GRK6 | 0.13042660 |
| 161 | RPS6KA3 | 0.12978243 |
| 162 | MAP2K2 | 0.11184499 |
| 163 | ATR | 0.10710019 |
| 164 | FLT3 | 0.10473502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 6.39396963 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.35511072 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.87216796 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.64102114 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.13027472 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.09443049 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.81725810 |
| 8 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.63131004 |
| 9 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.61262334 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.49404681 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44219277 |
| 12 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.30850264 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.27566913 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26852145 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.18603615 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.08270586 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.05111015 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.94223714 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.93418508 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.91758454 |
| 21 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.88464661 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.86957600 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.85883641 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.85463506 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.83658811 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.78188909 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.78042315 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.75555186 |
| 29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.75366836 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74850312 |
| 31 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.73784392 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.69875826 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.68600865 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.67836737 |
| 35 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.65832578 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60082287 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 1.57992863 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.57504176 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57243766 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57160129 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54391848 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.54086359 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.53177993 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.52338047 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.51214438 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47332768 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.46835121 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46413192 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40538936 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.38021894 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37342827 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 1.36959674 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34195911 |
| 54 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.33092394 |
| 55 | Adherens junction_Homo sapiens_hsa04520 | 1.32282447 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28860795 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.27822388 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.19603111 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.18584995 |
| 60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.18078990 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.17961382 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16776919 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16695982 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15620448 |
| 65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.14722067 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.13548647 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10713535 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10695781 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08905552 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07406872 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.02844916 |
| 72 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.01751281 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01351277 |
| 74 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.00742523 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99334068 |
| 76 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.99022392 |
| 77 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.97386382 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97297269 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96433813 |
| 80 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96382156 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.93578158 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92803416 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89089141 |
| 84 | Influenza A_Homo sapiens_hsa05164 | 0.87369374 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85323646 |
| 86 | Homologous recombination_Homo sapiens_hsa03440 | 0.82568602 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79970332 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79039991 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.78256218 |
| 90 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77897719 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75935094 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72926294 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71203596 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70700218 |
| 95 | Spliceosome_Homo sapiens_hsa03040 | 0.70472054 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69716736 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.68642002 |
| 98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.68437466 |
| 99 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.65059069 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64686497 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64212690 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.62465610 |
| 103 | Apoptosis_Homo sapiens_hsa04210 | 0.59811276 |
| 104 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58940919 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58795487 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58477901 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.58102308 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56610340 |
| 109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.54954888 |
| 110 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54640085 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54562603 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54370683 |
| 113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53322414 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.53316871 |
| 115 | Hepatitis B_Homo sapiens_hsa05161 | 0.53163887 |
| 116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52859393 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52335039 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52315510 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52309173 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51534216 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51339814 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.50170998 |
| 123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49043338 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48921884 |
| 125 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48356956 |
| 126 | RNA transport_Homo sapiens_hsa03013 | 0.46702606 |
| 127 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46361625 |
| 128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46189353 |
| 129 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44861718 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44532414 |
| 131 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41169485 |
| 132 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41168666 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40805614 |
| 134 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40524951 |
| 135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39876267 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38840768 |
| 137 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38835400 |
| 138 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38410039 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37227543 |
| 140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36380836 |
| 141 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35621216 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33912389 |
| 143 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33749586 |
| 144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33334633 |
| 145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30921915 |
| 146 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29914833 |
| 147 | Legionellosis_Homo sapiens_hsa05134 | 0.29086958 |
| 148 | Gap junction_Homo sapiens_hsa04540 | 0.26348427 |
| 149 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.25891944 |
| 150 | Phagosome_Homo sapiens_hsa04145 | 0.25748554 |
| 151 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25416306 |
| 152 | Focal adhesion_Homo sapiens_hsa04510 | 0.25080276 |
| 153 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.23703005 |
| 154 | Insulin resistance_Homo sapiens_hsa04931 | 0.23157058 |
| 155 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23097467 |
| 156 | Prion diseases_Homo sapiens_hsa05020 | 0.22730391 |
| 157 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.22084429 |
| 158 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20906852 |
| 159 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20902664 |
| 160 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20517745 |
| 161 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20096704 |
| 162 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19799518 |
| 163 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18957754 |
| 164 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.17560512 |
| 165 | Prostate cancer_Homo sapiens_hsa05215 | 0.14949192 |
| 166 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14838850 |
| 167 | Measles_Homo sapiens_hsa05162 | 0.13384847 |

